{"id":271975,"date":"2018-10-01T20:14:02","date_gmt":"2018-10-01T20:14:02","guid":{"rendered":"http:\/\/www.abnewswire.com\/pressreleases\/?p=271975"},"modified":"2018-10-01T20:14:02","modified_gmt":"2018-10-01T20:14:02","slug":"hemostats-market-size-share-analysis-trends-and-forecast-2023-marketsandmarkets","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/hemostats-market-size-share-analysis-trends-and-forecast-2023-marketsandmarkets_271975.html","title":{"rendered":"Hemostats Market Size, Share, Analysis, Trends and Forecast – 2023 | MarketsandMarkets"},"content":{"rendered":"
\"\"<\/a><\/p>\n
\n
“Market Key Players:
\nThe major players in the hemostats market include CR Bard, Inc. (US), B. Braun Melsungen AG (Germany), Baxter International, Inc. (US), Integra LifeSciences (US), Marine Polymer Technologies, Inc. (US), Teleflex (US), Ethicon, Inc. (U”<\/div>\n<\/div>\n<\/div>\n
The hemostats market is expected to reach 3.03 billion by 2023 from USD 2.27 billion in 2018, at a CAGR of 6.0%. Rapidly growing number of surgical procedures, increasing number of regulatory approvals, growing incidence of sports-related injuries and spinal ailments, and rising focus on effective blood loss management in patients during surgeries are the major factors driving the growth of this market.<\/div>\n

The Hemostats Market<\/a> is segmented into basis of product, Based on application, Based on formulation & geographic<\/strong><\/p>\n

On the basis of product, the hemostats market is segmented into thrombin-based hemostats, oxidized regenerated cellulose-based hemostats, combination hemostats, gelatin-based hemostats, and collagen-based hemostats. The combination hemostats segment is expected to grow at the highest CAGR during the forecast period. Based on application, the hemostats market has been segmented into neurological surgery, cardiovascular surgery, general surgery, orthopedic surgery, gynecological surgery, reconstructive surgery, and other surgeries.Based on application, the hemostats market has been segmented into neurological surgery, cardiovascular surgery, general surgery, orthopedic surgery, gynecological surgery, reconstructive surgery, and other surgeries.<\/p>\n

Hemostats Market, by Application<\/strong>
o Orthopedic Surgery
o General Surgery
o Neurological Surgery
o Cardiovascular Surgery
o Reconstructive Surgery
o Gynecological Surgery
o Other Surgeries<\/p>\n

Geographically,<\/strong> the hemostats market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Asia Pacific is estimated to register the highest growth rate during the forecast period, primarily due to large patient population base, increasing awareness regarding advanced hemostat products, improving healthcare infrastructure, growing medical tourism, and increasing number of elderly people in the region.<\/p>\n

PDF Brochure:<\/strong> https:\/\/www.marketsandmarkets.com\/pdfdownload.asp?id=9571619<\/a><\/p>\n

Most companies in the hemostats market adopted product launches & approvals and acquisitions as their key growth strategies to enhance their shares in the market. These strategies accounted for the largest share of the overall growth strategies mapped from 2015 to 2018. Some of the leading players who adopted these strategies include Ethicon, Inc. (US), Baxter International (US), Z-Medica (US), and Teleflex Incorporated (US).<\/p>\n

Johnson & Johnson held the leading position in the global hemostats market in 2017.<\/strong> Ethicon, a subsidiary of Johnson & Johnson develops, manufactures, and markets technologically innovative hemostats. The company’s broad product portfolio includes surgical snow absorbable hemostats, surgicel fibrillar absorbable hemostats, surgicel nu-knit absorbable hemostats, and surgicel powder absorbable hemostats, among other products. Baxter International ranked second in the hemostats market in 2017.<\/strong> The company has a strong synthetic hemostats product portfolio. The company has a strong presence across North America, Europe, the Middle East, Africa, and Asia Pacific. Some of the major end users of the company include hospitals, nursing homes, kidney dialysis centers, clinical and medical research laboratories, rehabilitation centers, doctors’ offices, and patients at home under physician supervision. The company’s robust manufacturing capabilities and wide distribution network across has enabled it to establish a strong foothold in the hemostats market.<\/p>\n

Recent Market Developments:<\/strong><\/p>\n

Recent developments are helpful to know the market trend and growth strategies adopted by players in the market. For instance, in this market, the number of new products launched and product approvals has increased in the last three years (2015 to 2018). In the updated version of report, product approvals strategy adopted by players in this market accounted for 52.0% of total developments.<\/p>\n

Press Release:<\/strong> https:\/\/www.marketsandmarkets.com\/PressReleases\/hemostats.asp<\/a> <\/p>\n

About MarketsandMarkets™<\/strong><\/p>\n

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities\/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.<\/p>\n

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations\/disruptions early to the market by providing them research ahead of the curve.<\/p>\n

MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledgestore” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.<\/p>\n

Media Contact<\/span>
Company Name:<\/strong> MarketsandMarkets
Contact Person:<\/strong> Mr. Shelly Singh
Email:<\/strong> Send Email<\/a>
Phone:<\/strong> 1-888-600-6441
Address:<\/strong>630 Dundee Road Suite 430
City:<\/strong> Northbrook
State:<\/strong> IL
Country:<\/strong> United States
Website:<\/strong> https:\/\/www.marketsandmarkets.com\/Market-Reports\/hemostats-market-9571619.html<\/a><\/p>\n

<\/object><\/p>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

“Market Key Players: The major players in the hemostats market include CR Bard, Inc. (US), B. Braun Melsungen AG (Germany), Baxter International, Inc. (US), Integra LifeSciences (US), Marine Polymer Technologies, Inc. (US), Teleflex (US), Ethicon, Inc. (U” The hemostats market … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":0,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401],"tags":[],"class_list":["post-271975","post","type-post","status-publish","format-standard","hentry","category-Business"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/271975","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=271975"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/271975\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=271975"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=271975"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=271975"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}